ModelEdge

Seres Therapeutics
0001644164
Filing TypeSC 13D/A
Filing Date7/21/2022
Updated7/22/22, 7:34 AM

Filing

SC 13D/A
Earnings Release

Exhibits

SC 13D/AAmended Schedule 13D - Ownership Report
EX-99.3EX-99.3